GolinoTech (Cabergoline) is a prolactin inhibitor drug. Cabergoline is a long acting Dopamine receptor agonist with a high affinity for D2 receptors. It acts by direct stimulation of the D2 receptors on pituitary lactotrophs, thus inhibiting prolactin secretion.